|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2,579.20 INR | +3.05% |
|
+6.27% | +49.78% |
| Market Cap | 412B 4.32B 3.76B 3.5B 3.21B 6.06B 6.15B 41.2B 16.17B 205B 16.22B 15.87B 688B | P/E 2027 * |
33.1x | P/E 2028 * | 27x |
|---|---|---|---|---|---|
| Enterprise Value | 376B 3.94B 3.42B 3.18B 2.92B 5.52B 5.61B 37.53B 14.73B 187B 14.78B 14.45B 627B | EV / Sales 2027 * |
5.13x | EV / Sales 2028 * | 4.4x |
| Free-Float |
48.23% | Yield 2027 * |
0.78% | Yield 2028 * | 0.85% |
Last Transcript: Gland Pharma Limited
| 1 day | +3.05% | ||
| 1 week | +6.27% | ||
| Current month | +3.05% | ||
| 1 month | +4.75% | ||
| 3 months | +42.07% | ||
| 6 months | +36.06% | ||
| Current year | +49.78% |
| 1 week | 2,408.8 |  | 2,586 |
| 1 month | 2,351.1 | | 2,586 |
| Current year | 1,573.6 | | 2,586 |
| 1 year | 1,573.6 | | 2,586 |
| 3 years | 1,277.8 | | 2,586 |
| 5 years | 861 | | 4,350 |
| 10 years | 861 | | 4,350 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Director of Finance/CFO | - | 2019-09-29 | |
| Chief Operating Officer | - | 2026-04-05 | |
Jitendra Gangwal
CTO | Chief Tech/Sci/R&D Officer | - | 2026-02-17 |
| Director | Title | Age | Since |
|---|---|---|---|
Srinivas Sadu
CHM | Chairman | 57 | 2024-06-09 |
| Director/Board Member | 71 | 2018-02-06 | |
Naina Lal Kidwai
BRD | Director/Board Member | 69 | 2021-05-16 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 2/26/25 | Buy | 2,800 | 0.0017% | |||
| 6/28/24 | Sell | 1,950 | 0.0012% | |||
| 6/28/24 | Sell | 1,400 | 0.0008% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +3.05% | +6.27% | +30.08% | +94.07% | 4.32B | |
| -0.53% | -3.95% | +50.70% | +152.78% | 1,024B | |
| +0.21% | -2.68% | +53.20% | +50.87% | 618B | |
| -2.51% | -3.25% | +28.54% | +67.99% | 443B | |
| +1.02% | -1.08% | +39.69% | +33.43% | 349B | |
| -0.02% | -1.65% | +33.64% | +41.93% | 297B | |
| -4.82% | -7.67% | +6.86% | +9.17% | 264B | |
| +0.33% | -5.83% | -1.77% | -42.71% | 209B | |
| -0.64% | +2.43% | +29.74% | +67.16% | 208B | |
| -0.82% | +0.70% | +15.05% | +72.05% | 162B | |
| Average | -0.19% | -0.69% | +28.57% | +54.67% | 357.81B | |
| Weighted average by Cap. | +0.05% | -2.16% | +36.75% | +73.15% |
| 2027 * | 2028 * | |
|---|---|---|
| Net sales | 73.22B 767M 667M 621M 570M 1.08B 1.09B 7.32B 2.87B 36.45B 2.88B 2.82B 122B | 83.28B 872M 758M 706M 648M 1.22B 1.24B 8.32B 3.27B 41.46B 3.28B 3.2B 139B |
| Net income | 12.48B 131M 114M 106M 97.09M 183M 186M 1.25B 489M 6.21B 491M 480M 20.83B | 15.31B 160M 139M 130M 119M 225M 228M 1.53B 600M 7.62B 602M 589M 25.56B |
| Net Debt | -36.72B -385M -334M -311M -286M -540M -548M -3.67B -1.44B -18.28B -1.44B -1.41B -61.29B | -46.04B -482M -419M -390M -358M -677M -687M -4.6B -1.81B -22.92B -1.81B -1.77B -76.86B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-08-03 | ₹2,579.20 | +3.05% | 502,536 |
| 26-07-31 | ₹2,502.90 | -0.56% | 266,828 |
| 26-07-30 | ₹2,517.00 | -1.05% | 745,911 |
| 26-07-29 | ₹2,543.70 | +4.75% | 841,656 |
| 26-07-28 | ₹2,428.30 | +0.05% | 142,915 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- GLAND Stock
Select your edition
All financial news and data tailored to specific country editions
